Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple Sclerosis and Pregnancy: Current Considerations.
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Top ten research priorities for spinal cord injury: the methodology and results of a British priority setting partnership.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.
Keystone Symposium: Advances in the Knowledge and Treatment of Autoimmunity
Focal vibration in neurorehabilitation.
Interferon-β-1b: a review of its use in multiple sclerosis.
Dose comparison trial of sustained-release fampridine in multiple sclerosis.
Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Clinically feasible MTR is sensitive to cortical demyelination in MS.
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.

Pages